100 startups to invest in by 2026: 4 startups supported by IncubAlliance Paris-Saclay are among the top-ranked.
April 9, 2026
News
Kerys Software, Harmonix, Alatyr (SQYCub) and e-miRgency: four start-ups supported and/or passed through IncubAlliance Paris-Saclay are featured in the new selection of Challenges magazine, which publishes its annual ranking of the most promising French start-ups.

The magazine Challenges has just unveiled its 2026 edition of the ranking of «"100 startups to invest in"». Among the winners of this edition, four startups supported by IncubAlliance Paris-Saclay were selected.
This ranking, compiled by Challenges journalists based on a call for applications and recommendations from incubators and venture capital funds, distinguishes young independent French companies, less than four years old, seeking funding.
The 4 winning startups
Kerys Software: A deeptech software publisher that allows multiple work environments to be shared on a single computer in a completely secure manner and without compromising performance.
- Co-founders Thomas Girard, Thomas Brethomé, Sebastien Domergue, Sylvain Cassier
- To learn more: https://kerys.software/fr
Harmonix Winner of the Grand Jury Prize at the i-Lab 2025 competition, the startup is developing an innovative platform for the transport, encapsulation and IV administration of viral and non-viral gene therapies in the central nervous system.
- Co-founders Delphine GALEZOWSKI, Anthony DELALANDE
- Technology derived from CNRS
- Co-accompaniment with the Paris Saclay Cancer Cluster (PSCC)
- To learn more: https://www.harmonix-tech.com/
Alatyr (SQYCub) : Construction of robotic infrastructure for the orbital economy to enable data processing, AI and production in orbit.
- Co-founders Emeric Lhomme and Mathieu Chaize
- To learn more: https://www.alatyr.space/
e-miRgency : In vitro diagnostic medical device based on the direct detection and measurement of circulating microRNAs in the blood — biomarkers with high potential to improve early diagnosis and monitoring of treatments in oncology.
- Founder Olivier LAVERGNE
- Technology derived from : C2N (CNRS / Université Paris-Saclay / Université Paris Cité)
- Co-accompaniment with the Paris Saclay Cancer Cluster (PSCC)
- To learn more : https://www.e-mirgency.com/
Congratulations to the teams at’Harmonix, Kerys Software, Alatyr And e-miRgency Thank you for this wonderful recognition!
Find the complete selection of the 100 startups to invest in by 2026 at: https://www.challenges.fr/classements/start-up/